Paliperidone (9-hydroxyrisperidone) is the active ingredient in Invega extended-release tablets. Paliperidone is also the major active metabolite of Risperidone. Steady-state concentrations are typically attained within 4 to 5 days of dosing. Following daily administration of 12 mg extended release formulation, paliperidone steady state plasma concentrations ranged from 30 to 40 ng/mL.
Reporting limit determined each analysis
* Reference ranges may change over time. Please refer to the original patient report when evaluating results.
Days Test Performed
Monday - Sunday
8 - 12 days
Soft Order Code
Mayo FPALI (NMS Labs)
Looking to Order a Test?
We’ve provided helpful links to make ordering easy.
All specimens should be accompanied by a requisition.
Learn about how to properly label and where to ship specimens.
MLabs provides all the supplies necessary for the collection of specimens.
Visit our provider FAQ and learn about common questions to ordering tests.
Offsite Collection Instructions
Collect specimen in a red top tube (NO SST). Spin and aliquot into a plastic, screw capped tube. Send to Specimen Processing refrigerated
Specimen collected in anything but a red top tube
1 mL serum
0.5 mL serum
Test sent to Mayo Clinic Labs; performed by NMS labs